Dirty Money “Drug Short” episode and thyroid T3 Liothyronine

In the "Dirty Money" series on Netflix, the "Drug Short" episode (1) helped me understand some of the economic forces that may have influenced T3 / Liothyronine price hikes in the UK. It makes me concerned about the future of T3 pricing in Canada too. This episode focuses on Valeant, a Canadian pharmaceutical company that … Continue reading Dirty Money “Drug Short” episode and thyroid T3 Liothyronine